FDA approves Geron's groundbreaking study of embryonic cells - San Jose Mercury News: "A Menlo Park biotech firm said Friday that federal regulators will let it proceed with the world's first human test of a treatment made from embryonic stem cells, a much-anticipated but controversial study of patients with spinal cord injuries that had been placed on hold for nearly a year because of safety concerns.
If the treatment from Geron works, it 'would be revolutionary,' said Dr. Richard Fessler, a neurological surgeon at Northwestern University, who will lead the study of a stem-cell treatment designed to be injected into patients with spinal injuries to restore their motor function. 'The therapy would provide a viable treatment option for thousands of patients who suffer severe spinal cord injuries each year...'"
No comments:
Post a Comment